Association of P1635 and P1655 polymorphisms in dysbindin (DTNBP1) gene with schizophrenia

Acta Neuropsychiatrica

Volumn 24, Issue 3, 2012, Pages 155-159

  Alizadeh, Fatemeh ^a   Tabatabaiefar, Mohammad Amin ^a,b   Ghadiri, Mohammad ^c   Yekaninejad, Mir Saeed ^c   Jalilian, Nazanin ^a   Noori Daloii, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

association; dysbindin; polymorphism; schizophrenia

Indexed keywords

DYSBINDIN; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84861608852     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2011.00598.x     Document Type: Article

References (36)

1. Karayiorgou M, Gogos JA., A turning point in schizophrenia genetics. Neuron 1997; 19: 967-979. (Pubitemid 27512359)
2. Hanson DR, Gottesman II., Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 2005; 6: 7.
3. Gogos JA, Gerber DJ., Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 2006; 27: 226-233.
4. Iizuka Y, Sei Y, Weinberger DR, Straub RE., Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 2007; 27: 12390-12395. (Pubitemid 350085456)
5. Li D, He L., Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis. Schizophr Res 2007; 96: 112-118. (Pubitemid 47494624)
6. Owen MJ, Craddock N, Jablensky A., The genetic deconstruction of psychosis. Schizophr Bull 2007; 33: 905-911. (Pubitemid 47216654)
7. Harrison PJ, Owen MJ., Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003; 361: 417-419. (Pubitemid 36164980)
8. Veroni C, Grasso M, Macchia G, Ramoni C, Ceccarini M, Petrucci TC, Macioce P., Beta-dystrobrevin, a kinesin-binding receptor, interacts with the extracellular matrix components pancortins. J Neurosci Res 2007; 85: 2631-2639. (Pubitemid 47344565)
9. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ., Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001; 276: 24232-24241.
10. Pimm J, McQuillin A, Thirumalai S, et al., The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am J Hum Genet 2005; 76: 902-907. (Pubitemid 40563112)
11. Nazarian R, Starcevic M, Spencer MJ, Dell'Angelica EC., Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein. Biochem J 2006; 395: 587-598.
12. Knuesel I, Mastrocola M, Zuellig RA, Bornhauser B, Schaub MC, Fritschy JM., Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 1999; 11: 4457-4462. (Pubitemid 30009278)
13. Krystal JH, Sanacora G, Blumberg H, et al., Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002; 7 (Suppl. 1): S71-S80. (Pubitemid 34280651)
14. D'Sa C, Duman RS., Antidepressants and neuroplasticity. Bipolar Disord 2002; 4: 183-194. (Pubitemid 34591244)
15. McLeod TM, Lopez-Figueroa AL, Lopez-Figueroa MO., Nitric oxide, stress, and depression. Psychopharmacol Bull 2001; 35: 24-41.
16. Brambilla P, Perez J, Barale F, Schettini G, Soares JC., GABAergic dysfunction in mood disorders. Mol Psychiatry 2003; 8: 721-737. (Pubitemid 36976430)
17. Duman RS, Malberg J, Nakagawa S, D'Sa C., Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000; 48: 732-739.
18. Straub RE, Jiang Y, MacLean CJ, et al., Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-348. (Pubitemid 34800250)
19. Schwab SG, Knapp M, Mondabon S, et al., Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72: 185-190. (Pubitemid 36056855)
20. Tang JX, Zhou J, Fan JB, et al., Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 2003; 8: 717-718.
21. Kirov G, Ivanov D, Williams NM, et al., Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004; 55: 971-975. (Pubitemid 38581911)
22. De Luca V, Voineskos D, Shinkai T, Wong G, Kennedy JL., Untranslated region haplotype in dysbindin gene: analysis in schizophrenia. J Neural Transm 2005; 112: 1263-1267. (Pubitemid 41215929)
23. Van Den Bogaert A, Schumacher J, Schulze TG, et al., The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73: 1438-1443. (Pubitemid 38037434)
24. Kishimoto M, Ujike H, Motohashi Y, et al., The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 2008; 63: 191-196. (Pubitemid 350299318)
25. Benjamini Y, Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological) 1995; 57: 289-300.
26. Benjamini Y, Krieger AM, Yekutieli D., Adaptive linear step-up procedures that control the false discovery rate. Biometrika 2006; 93: 491-507. (Pubitemid 44599846)
27. Stephens M, Smith NJ, Donnelly P., A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989. (Pubitemid 32289743)
28. Tochigi M, Zhang X, Ohashi J, et al., Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res 2006; 56: 154-158. (Pubitemid 44399806)
29. Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS., The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neurosci Lett 2006; 407: 101-106. (Pubitemid 44397234)
30. Galehdari H, Ajam T, Pooryasin A, Foroughmand AM, Kazeminejad SR., Combined effect of polymorphic sites in the DTNBP1 and GRIN1 genes on schizophrenia. MJIRI 2010; 24: 5-10.
31. Tosato S, Ruggeri M, Bonetto C, et al., Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 647-659. (Pubitemid 47077150)
32. Williams NM, Preece A, Morris DW, et al., Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004; 61: 336-344. (Pubitemid 38451542)
33. Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, Owen MJ, O'Donovan MC., Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005; 14: 1947-1954. (Pubitemid 41418031)
34. Numakawa T, Yagasaki Y, Ishimoto T, et al., Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004; 13: 2699-2708. (Pubitemid 39485418)
35. Talbot K, Eidem WL, Tinsley CL, et al., Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004; 113: 1353-1363. (Pubitemid 39069934)
36. Weickert CS, Straub RE, McClintock BW, et al., Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004; 61: 544-555. (Pubitemid 38747309)